Endpoint definition
↥Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions
Apply sex-specific rule None
Extra metadata
No definition available.
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions
Apply sex-specific rule None
Extra metadata
List of similar endpoints to
Exclude non-diabetic causes for injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1270 | 631 | 639 |
| Unadjusted prevalence (%) | 0.49 | 0.43 | 0.57 |
| Mean age at first event (years) | 70.17 | 70.86 | 69.50 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.03 | 2.46 [1.51, 4.04] | 3.4e-4 | 256 |
| 15 years | 0.02 | 2.92 [1.95, 4.38] | 2.2e-7 | 249 |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: DM_EYE_OPER_FOR_NON_DIAB_EXCLUSION – Exclude non-diabetic causes for injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
GWS hits:
before Exclude non-diabetic causes for injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
after Exclude non-diabetic causes for injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
Loading survival analyses plot
Loading survival analyses table